Hyosung TNC Corp (298020)
Korea Stock Exchange · Korea · prices in KRW · close of 19 Oct 2026
Key indicators
| Last close | KRW 276,000.00 |
|---|---|
| 52-week range | 190,447.23 – 557,000.00 |
| Return, 1 month / 3 months | −17.5% / +1.5% |
| Return, 1 year / 3 years | +34.8% / −16.2% |
| Trend | Below its 200-day average |
| RSI (14) | 39 |
| Volatility (1 year) | 67.2% |
| Worst drawdown (1 year) | -50.7% |
| Average daily value traded | 6,168.87M KRW |
| Dividend yield | 3.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Hyosung TNC Corp is a Korean textile and fibre company based in Seoul. It makes spandex fibre, sold under the creora brand, along with nylon and polyester fibres and industrial yarns used in products such as tyre cord and airbags. Its customers are textile mills, garment makers, tyre manufacturers and industrial users, and it supplies these markets in Korea and around the world.
On this site Hyosung TNC Corp appears as a stock on the Korea Stock Exchange (Korea), code 298020, with prices in South Korean won (KRW). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Hyosung TNC Corp (298020) trades on the Korea Stock Exchange in Korea. It last closed at KRW 276,000.00 on 19 October 2026.
Its price-based Market X-Ray is 46 out of 100 (a weak price profile), ranking 560 of 934 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 34.8% and over the last three months it rose 1.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Korea Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 32 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -20.8% | ||
| From 52-week high | -48.4% | ||
| Momentum | 52 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 1.5% | ||
| 6-month return | -40.5% | ||
| 12-month return, skipping the last month | 63.3% | ||
| Stability (higher is calmer) | 32 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 67.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -50.7% | ||
| Liquidity | 79 · Strong | Trades actively. | |
| Average daily value traded | 6,168.87M KRW | ||
| Zero-volume days | 0.0% | ||
| Income | 55 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.7% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +1.8% |
|---|---|
| 1 month | −17.5% |
| 3 months | +1.5% |
| 6 months | −40.5% |
| 1 year | +34.8% |
| 3 years | −16.2% |
| 5 years | – |
Signals
| 50-day / 200-day average | 317,150.00 / 348,497.96 |
|---|---|
| Golden / death cross (60 days) | Death, 52 days ago |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 13,712.66 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Dec 2025 | KRW 10,100.0000 |
| 27 Dec 2024 | KRW 10,000.0000 |
| 27 Dec 2023 | KRW 10,000.0000 |
| 28 Dec 2022 | KRW 10,000.0000 |
| 29 Dec 2021 | KRW 50,000.0000 |
| 29 Dec 2020 | KRW 5,000.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Korea Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.